insights_auto
Why is BMY down 3.83%?
Dive Deeperchevron_right
BMY:NYSE
Bristol-Myers Squibb Co
$58.81
arrow_downward
-3.83%(-2.34) 1D
$58.80
arrow_downward
-0.02% (-0.010)bedtimeAfter hours
Closed: Oct 5, 4:00:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
$59.89
High
$60.15
Low
$58.33
Mkt. cap
120.13B
Avg. vol.
10.43M
Volume
19.24M
Dividend
4.28%
Quarterly dividend
$0.63
Ex-dividend date
Oct 2, 2026
P/E ratio
12.95
52-wk high
$68.64
52-wk low
$42.52
EPS
$4.54
Beta
0.19
Shares outstanding
2.04B
No. of employees
32K
Open
$59.89
High
$60.15
Low
$58.33
Mkt. cap
120.13B
Avg. vol.
10.43M
Volume
19.24M
Dividend
4.28%
Quarterly dividend
$0.63
Ex-dividend date
Oct 2, 2026
P/E ratio
12.95
52-wk high
$68.64
52-wk low
$42.52
EPS
$4.54
Beta
0.19
Shares outstanding
2.04B
No. of employees
32K
News stories
From web sources and news partners
Yahoo Finance
·
43 minutes ago
Bristol Myers (BMY) Stock is Trading Below 10 Times Forward Earnings. Here’s Why it Matters
AD HOC NEWS
·
1 hour ago
Bristol Myers Squibb stock falls 3.97 percent on pipeline doubts
GuruFocus
·
1 hour ago
Bristol-Myers Squibb Co (BMY) Shares Fall 3.8% -- GF Value Says Still Overvalued
News Corp
·
2 hours ago
Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32.5K
Founded1887
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitebms.com